PERLMAN ANDREW J 4
4 · ISTA PHARMACEUTICALS INC · Filed Jun 15, 2012
Insider Transaction Report
Form 4
PERLMAN ANDREW J
Director
Transactions
- Disposition to Issuer
Option (right to buy)
2012-06-06−20,000→ 0 totalExercise: $3.89Exp: 2021-12-05→ Common Stock (20,000 underlying) - Disposition to Issuer
Option (right to buy)
2012-06-06−20,000→ 0 totalExercise: $4.58Exp: 2020-12-06→ Common Stock (20,000 underlying) - Disposition to Issuer
Option (right to buy)
2012-06-06−11,100→ 0 totalExercise: $0.79Exp: 2018-12-10→ Common Stock (11,100 underlying) - Disposition to Issuer
Option (right to buy)
2012-06-06−11,100→ 0 totalExercise: $6.90Exp: 2017-10-11→ Common Stock (11,100 underlying) - Disposition to Issuer
Common Stock
2012-06-06$9.10/sh−4,932$44,881→ 0 total - Disposition to Issuer
Option (right to buy)
2012-06-06−20,000→ 0 totalExercise: $4.72Exp: 2019-12-07→ Common Stock (20,000 underlying) - Disposition to Issuer
Option (right to buy)
2012-06-06−20,000→ 0 totalExercise: $5.75Exp: 2016-04-27→ Common Stock (20,000 underlying)
Footnotes (7)
- [F1]Disposed of pursuant to agreement and plan of merger by and among the Company, Bausch & Lomb Incorporated and Inga Acquisition Corporation, as amended (the "Merger Agreement") in exchange for $9.10 per share, without interest, less any applicable withholding tax, on the effective date of the merger.
- [F2]The option which was unvested was cancelled in the Merger Agreement in exchange for a cash payment equal to $5.21 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10 of $9.10).
- [F3]The option which was fully vested on 12/06/11 was cancelled in the Merger Agreement in exchange for a cash payment equal to $4.52 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).
- [F4]The option which was fully vested on 12/07/10 was cancelled in the Merger Agreement in exchange for a cash payment equal to $4.38 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).
- [F5]The option which was fully vested on 12/10/09 was cancelled in the Merger Agreement in exchange for a cash payment equal to $8.31 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).
- [F6]The option which was fully vested on 10/11/08 was cancelled in the Merger Agreement in exchange for a cash payment equal to $2.20 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).
- [F7]The option which was fully vested on 4/27/07 was cancelled in the Merger Agreement in exchange for a cash payment equal to $3.35 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).